EUROPEAN HEMATOLOGY ASSOCIATION -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2020-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 7.076.366 423.606 2
2021 0 8.728.185 0 1
2020 0 6.715.625 664.250 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMIC MEDICAL CENTRE AMSTERDAM2
BAYER2
CELGENE MANAGEMENT SARL2
ERASMUS UNIVERSITEIT ROTTERDAM2
OSPEDALE PEDIATRICO BAMBINO GESU2
STICHTING VUMC2
UNIVERSIDAD DE NAVARRA2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AHEAD THERAPEUTICS SL1
ANICELLS1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION INTERNATIONALE DE LA MUTUALITE ASBL1
ASTELLAS PHARMA EUROPE BV1
BIOKIT RESEARCH & DEVELOPMENT SLU1
BIOSCI CONSULTING BVBA1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHINO1
DRESDEN UNIVERSITY OF TECHNOLOGY1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION1
EUROPEAN RESEARCH INITIATIVE ON CLL EV1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
FUNDACION HOSPITAL LA FE1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON1
GENOME RESEARCH1
GESUNDHEIT OSTERREICH1
GMV SOLUCIONES GLOBALES INTERNET SAU1
GPOH GEMEINNUTZIGE1
GROUPE FRANCOPHONE DES MYELODYSPLASIES1
HELMHOLTZZENTRUM DRESDENROSSENDORF EV1
HOSPITAL CLINIC DE BARCELONA1
IMMUDEX APS1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INNOVATION ACTA1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUT NATIONAL DU CANCER GIP1
ISTITUTO NAZIONALE DI FISICA NUCLEARE1
JANSSEN PHARMACEUTICA NV1
KATHOLIEKE UNIVERSITEIT LEUVEN1
LEUKANET EV1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LYSARC1
MASARYKOVA UNIVERZITA1
MEDISAPIENS OY1
MEDIZINISCHE UNIVERSITAET WIEN1
MENARINI RICERCHE1
MILTENYI BIOTEC BV & CO KG1
MLL MUNCHNER LEUKAMIELABOR1
MYELOMA PATIENTS EUROPE AISBL1
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE1
NOVARTIS PHARMA1
NUROMEDIA1
OPTIMEDIS1
PFIZER LIMITED1
ROYAL COLLEGE OF SURGEONS IN IRELAND1
SEMMELWEIS UNIVERSITY OF MEDICINE1
SORBONNE UNIVERSITE1
STICHTING SANQUIN BLOEDVOORZIENING1
STIFTUNG ELN FOUNDATION1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
TCURX1
TECHNISCHE UNIVERSITAET MUENCHEN1
THE LYMPHOMA STUDY ASSOCIATION1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAET ULM1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITAT AUTONOMA DE BARCELONA1
UNIVERSITEIT ANTWERPEN1
UNIVERSITEIT VAN AMSTERDAM1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF BOLOGNA1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UNIVERSITY OF OSLO1
UNIVERZITA KOMENSKEHO V BRATISLAVE1
VIB VZW1

Constancy:

Total number of partners: 94
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 94
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-12-01Affordability and Sustainability improvements by using new pricing, Cost-Effectiveness and ReimbursemenT models to Appraise iNnovative health technologies ASCERTAINparticipant4.966.71610
2022-10-01An integrated approach to restore tolerance in autoimmune disease TOLERATEparticipant2.109.65018
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541